LeylaOShuneMD

PubMed

• 1 citations
  Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias.
  William Wesson, Nausheen Ahmed, Aliya Rashid, Carine Tabak, Emerson Logan, Jose Marchena-Burgos, Maggie Nelson, James A Davis, Mary McGann, Leyla Shune, Marc Hoffmann,...> ;European Journal of Haematology. 2024 Apr 1
• Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review.
  Muhammad Fareed Khalid, Muhammad Kashif Amin, Ali H Mushtaq, Atif Butt, Iqra Anwar, Moazzam Shahzad, Mohammad Ammad-Ud-Din, Usman Ilyas, Sibgha Gull Chaudhary, Naushee...> ;Hematology/oncology and Stem Cell Therapy. 2024 Mar 22
• Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
  Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya M Wildes, Sarah A Holstein, Larry D Anderson Jr, Ashraf Bad...> ;British Journal of Haematology. 2024 Mar 19
• Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
  Ahn, I., Brander, D., Ren, Y., Zhou, Y., Tyekucheva, S., Walker, H., Black, R., Montegaard, J., Alencar, A., Shune, L., Omaira, M., Jacobson, C., Armand, P., Ng, S., C...> ;Blood Advances. 2024 Feb 27
• Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Mu...
  Gagelmann, N., Dima, D., Merz, M., Hashmi, H., Ahmed, N., Tovar, N., Oliver-Caldés, A., Stölzel, F., Rathje, K., Fischer, L., Born, P., Schäfer, L., Albici, A., Schub,...> ;Journal of Clinical Oncology. 2024 Feb 15
• Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world m...
  Raza, S., Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Jo...> ;British Journal of Haematology. 2024 Apr 1
• 1 citations
  Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.
  Amin, M., DeJarnette, S., Li, K., Mushtaq, M., Shahzad, M., Lutfi, F., Al-Ramahi, J., Ahmed, N., Bansal, R., Abdelhakim, H., Shune, L., Abdallah, A., Abhyankar, S., Mc...> ;Leukemia & Lymphoma. 2024 Apr 1
• Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
  Amin, M., Mushtaq, M., Joe S Al-Ramahi, Moazzam Shahzad, Andrea Nguyen, Kevin Li, Muhammad Kashif Amin, Nausheen Ahmed, Forat Lutfi, Shaun DeJarnette, Sibgha Gull Chau...> ;Bone Marrow Transplantation. 2024 Jan 1
• Exploring the High-Grade and Refractory Neurotoxicity of Teclistamab: An Underreported Entity.
  Nelson, M., Hamideh, J., Mahmoudjafari, Z., Lutfi, F., Abdallah, A., Nashatizadeh, M., Ahmed, N., Shune, L.> ;Cureus. 2023 Nov 1
• 4 citations
  Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
  Surbhi Sidana, Lauren C Peres, Hamza Hashmi, Hitomi Hosoya, Christopher Ferreri, Jack Khouri, Danai Dima, Shebli Atrash, Peter Voorhees, Gary Simmons, Douglas W Sborov...> ;Haematologica. 2024 Mar 1
• 14 citations
  Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
  Castaneda Puglianini, O., Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk, Douglas W Sborov, Charlotte B Wagner, M Hakan...> ;Blood Cancer Journal. 2023 Aug 9
• 3 citations
  Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
  Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E Brammer, Tatyana A Feldman, Marcelo Capra, Elizabeth A Brem, Santosh Nair, Phillip Scheinberg, Juliana Pe...> ;Blood Advances. 2023 Oct 24
• 12 citations
  A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
  Michael J Dickinson, Pere Barba, Ulrich Jäger, Nirav N Shah, Didier Blaise, Javier Briones, Leyla Shune, Nicolas Boissel, Attilio Bondanza, Luisa Mariconti, Anne-Laure...> ;Cancer Discovery. 2023 Sep 6
• A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the G...
  Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya Wildes, Sarah A Holstein, Larry D Anderson Jr, Ashraf Badro...> ;Future Oncology. 2022 Dec 1
• 3 citations
  Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
  Al-Ola Abdallah, Zahra Mahmoudjafari, Nausheen Ahmed, Wei Cui, Leyla Shune, Joseph McGuirk, Meera Mohan, Ghulam Rehman Mohyuddin, Aimaz Afrough, Omar Alkharabsheh, She...> ;European Journal of Haematology. 2023 Jun 1
• Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexametha...
  Omar Alkharabsheh, Polina Bellman, Zahra Mahmoudjafari, Wei Cui, Shebli Atrash, Barry Paul, Hamza Hashmi, Leyla Shune, Nausheen Ahmed, Al-Ola Abdallah> ;Journal of Hematology. 2023 Feb 1
• 1 citations
  Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to ...
  Hamza Hashmi, Shebli Atrash, Jayanshu Jain, Ghena Khasawneh, Meera Mohan, Zahra Mahmoudjafari, Wei Cui, Joseph McGuirk, Leyla Shune, Nausheen Ahmed, Al-Ola Abdallah> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 53 citations
  Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.
  Doris K Hansen, Surbhi Sidana, Lauren C Peres, Christelle Colin Leitzinger, Leyla Shune, Alexandria Shrewsbury, Rebecca Gonzalez, Douglas W Sborov, Charlotte Wagner, D...> ;Journal of Clinical Oncology. 2023 Apr 10
• 10 citations
  Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.
  Tahani Atieh, Shebli Atrash, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Susana Hajjar, Zahra Mahmoudjafari, Julie Quick, Anne Wishna, Justin Riffel, Joseph McG...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Dec 1
• Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis.
  Razwana Khanam, Moazzam Shahzad, Sibgha Gull Chaudhary, Fatima Ali, Zunairah Shah, Pranali S Pachika, Zahoor Ahmed, Asmi Chattaraj, Adeel Masood, Nausheen Ahmed, Rajat...> ;Leukemia & Lymphoma. 2022 Nov 1
• 4 citations
  Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
  Al-Ola Abdallah, Zahra Mahmoudjafari, Tahani Atieh, Nausheen Ahmed, Wei Cui, Leyla Shune, Meera Mohan, Joseph McGuirk, Cassie Remker, Margaret Foss, Ellie Karloff, Hea...> ;European Journal of Haematology. 2022 Nov 1
• 2 citations
  Palliative care utilization, transfusion burden, and end-of-life care for patients with multiple myeloma.
  Geoffrey McInturf, Kimberly Younger, Courtney Sanchez, Charles Walde, Al-Ola Abdallah, Nausheen Ahmed, Leyla Shune, Douglas W Sborov, Amandeep Godara, Brian McClune, C...> ;European Journal of Haematology. 2022 Nov 1
• 34 citations
  Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access.
  Nausheen Ahmed, Moazzam Shahzad, Ernie Shippey, Rajat Bansal, Muhammad Umair Mushtaq, Zahra Mahmoudjafari, Muhammad Salman Faisal, Marc Hoffmann, Al-Ola Abdallah, Clin...> ;Transplantation and Cellular Therapy. 2022 Jul 1
• 5 citations
  Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies.
  Raheel Sufian Siddiqui, Sibgha Gull Chaudhary, Moazzam Shahzad, Iqra Anwar, Ali Hussain, Nausheen Ahmed, Sunil Hari Abhyankar, Leyla Shune, Peiman Hematti, Heather Mal...> ;Leukemia & Lymphoma. 2022 Jul 1
• 1 citations
  Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma.
  Kellen Gil, Saqib Abbasi, Kathan Mehta, Brian McClune, Douglas Sborov, Nausheen Ahmed, Al-Ola Abdallah, Siddhartha Ganguly, Joseph McGuirk, Leyla Shune, Ghulam Rehman ...> ;Clinical Hematology International. 2022 Jun 1
• Join now to see all

Abstracts/Posters

• Inpatient HospitalizationÍs Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient...
  Leyla Shune, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019